EP
ADPT icon

Elkfork Partners’s Adaptive Biotechnologies ADPT Stock Holding History

Elkfork Partners’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$24K Buy
+770
New +$31.4K ﹤0.01% 1021

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Elkfork Partners's ADPT Position: Q3 2019 in Review

Elkfork Partners opened a new position in Adaptive Biotechnologies (ADPT) in Q3 2019: 770 shares worth $24K. The stake represents ﹤0.01% of the portfolio and ranks #1021 among its holdings.

117 funds tracked by Wall St. Rank hold ADPT as of Q3 2019.

  • Elkfork Partners held 770 shares of Adaptive Biotechnologies worth $24K as of Q3 2019.
  • Adaptive Biotechnologies was a new Elkfork Partners position in Q3 2019.
  • Adaptive Biotechnologies made up ﹤0.01% of Elkfork Partners's portfolio in Q3 2019, its #1021 holding.
  • 117 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.